These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31471837)

  • 1. Validation of the online prediction model CancerMath in the Dutch breast cancer population.
    Hoveling LA; van Maaren MC; Hueting T; Strobbe LJA; Hendriks MP; Sonke GS; Siesling S
    Breast Cancer Res Treat; 2019 Dec; 178(3):665-681. PubMed ID: 31471837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the online prediction tool PREDICT v. 2.0 in the Dutch breast cancer population.
    van Maaren MC; van Steenbeek CD; Pharoah PDP; Witteveen A; Sonke GS; Strobbe LJA; Poortmans PMP; Siesling S
    Eur J Cancer; 2017 Nov; 86():364-372. PubMed ID: 29100191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia.
    Miao H; Hartman M; Verkooijen HM; Taib NA; Wong HS; Subramaniam S; Yip CH; Tan EY; Chan P; Lee SC; Bhoo-Pathy N
    BMC Cancer; 2016 Oct; 16(1):820. PubMed ID: 27769212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
    Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
    Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison Between the Online Prediction Models CancerMath and PREDICT as Prognostic Tools in Thai Breast Cancer Patients.
    Polchai N; Sa-Nguanraksa D; Numprasit W; Thumrongtaradol T; O-Charoenrat E; O-Charoenrat P
    Cancer Manag Res; 2020; 12():5549-5559. PubMed ID: 32753968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMath.
    Karapanagiotis S; Pharoah PDP; Jackson CH; Newcombe PJ
    Clin Cancer Res; 2018 May; 24(9):2110-2115. PubMed ID: 29444929
    [No Abstract]   [Full Text] [Related]  

  • 7. Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands.
    van Steenbeek CD; van Maaren MC; Siesling S; Witteveen A; Verbeek XAAM; Koffijberg H
    BMC Med Res Methodol; 2019 Jun; 19(1):117. PubMed ID: 31176362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based validation of the prognostic model PREDICT for early breast cancer.
    Wishart GC; Bajdik CD; Azzato EM; Dicks E; Greenberg DC; Rashbass J; Caldas C; Pharoah PD
    Eur J Surg Oncol; 2011 May; 37(5):411-7. PubMed ID: 21371853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012.
    van Maaren MC; Lagendijk M; Tilanus-Linthorst MMA; de Munck L; Pijnappel RM; Schmidt MK; Wesseling J; Koppert LB; Siesling S
    Eur J Cancer; 2018 Sep; 101():134-142. PubMed ID: 30059817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data.
    Gray E; Marti J; Brewster DH; Wyatt JC; Hall PS;
    Br J Cancer; 2018 Oct; 119(7):808-814. PubMed ID: 30220705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer.
    van Ramshorst MS; van der Heiden-van der Loo M; Dackus GM; Linn SC; Sonke GS
    Breast Cancer Res Treat; 2016 Jul; 158(2):361-71. PubMed ID: 27357813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conditional model predicting the 10-year annual extra mortality risk compared to the general population: a large population-based study in Dutch breast cancer patients.
    van Maaren MC; Kneepkens RF; Verbaan J; Huijgens PC; Lemmens VEPP; Verhoeven RHA; Siesling S
    PLoS One; 2019; 14(1):e0210887. PubMed ID: 30677053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients.
    Lagendijk M; van Maaren MC; Saadatmand S; Strobbe LJA; Poortmans PMP; Koppert LB; Tilanus-Linthorst MMA; Siesling S
    Int J Cancer; 2018 Jan; 142(1):165-175. PubMed ID: 28884470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based validation of the prognostic model ADJUVANT! for early breast cancer.
    Olivotto IA; Bajdik CD; Ravdin PM; Speers CH; Coldman AJ; Norris BD; Davis GJ; Chia SK; Gelmon KA
    J Clin Oncol; 2005 Apr; 23(12):2716-25. PubMed ID: 15837986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancer.
    Rose BS; Jiang W; Punglia RS
    Breast Cancer Res Treat; 2015 Jul; 152(1):209-216. PubMed ID: 26041688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years.
    van Maaren MC; Strobbe LJA; Smidt ML; Moossdorff M; Poortmans PMP; Siesling S
    Eur J Cancer; 2018 Oct; 102():82-94. PubMed ID: 30144661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models.
    Laas E; Mallon P; Delomenie M; Gardeux V; Pierga JY; Cottu P; Lerebours F; Stevens D; Rouzier R; Reyal F
    Br J Cancer; 2015 Mar; 112(5):912-7. PubMed ID: 25590666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
    Chen HL; Zhou MQ; Tian W; Meng KX; He HF
    PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer.
    Yang Y; Wang Y; Deng H; Tan C; Li Q; He Z; Wei W; Zhou E; Liu Q; Liu J
    BMC Cancer; 2019 Jun; 19(1):541. PubMed ID: 31170946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.